MediBeacon
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Theodor-kutzer-ufer 1-3, Mannheim, Baden...Website
www.medibeacon.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About MediBeacon
MediBeacon is a medical technology company that specializes in the development of fluorescent tracer agents and transdermal measurement systems. Their flagship product, the Transdermal GFR System (TGFR), allows for non-invasive monitoring of kidney function through a sensor placed on the skin. The company targets a range of clients including leading academic centers, research institutes, contract research organizations, and pharmaceutical companies worldwide. MediBeacon aims to improve patient care and reduce healthcare costs through innovative solutions in nephrology, gastroenterology, ophthalmology, and surgical applications.Explore more
MediBeacon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MediBeacon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if MediBeacon has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on MediBeacon recently announced quarterly report
Check out if MediBeacon is spiking on competitors!
Product Launch: Get notified when MediBeacon launches new products
Funding: Get notified immidiatlly once MediBeacon has new funding data
Congratulate Masked Content for being promoted to Masked Content at MediBeacon
Click to see if MediBeacon had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
MediBeacon, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at MediBeacon
Find 2 more new buyers
Compare Similar Companies to MediBeacon
Compare insights from companies similar to MediBeacon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MediBeacon is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MediBeacon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MediBeacon.
MediBeacon financials insights
Gather financial insights about MediBeacon, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Debt
$5.1M
2013
Series A
$3.5M
2015
Unspecified
$5M
Private Equity
$22.4M
2017
Series B
$33.6M
Series C
$10M
2018
Debt
$4.6M
2019
Other Financing Round
$30M
MediBeacon Tech Stack
A closer look at the technologies used by MediBeacon
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Person-Based
Person-Based
MediBeacon News & Media
Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephology (JASN)
ST. LOUIS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that the peer-reviewed transdermal GFR measurement article published in the Journal of the American Society of Nephrology (JASN) has been recognized as one of five 2025 Editor’s Choice articles.1Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephrology (JASN)
ST. LOUIS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that the peer-reviewed transdermal GFR measurement article published in the Journal of the American Society of Nephrology (JASN) has been recognized as one of five 2025 Editor’s Choice articles.1MediBeacon® Next Generation TGFR™ System Receives FDA Approval
ST. LOUIS, Dec. 16, 2025 (GLOBE NEWSWIRE) -- MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced the U.S. Food and Drug Administration (FDA) has approved the next generation MediBeacon® TGFR™ System including the latest TGFR™ Reusable Sensor.MediBeacon to Present at the Upcoming American Society of Nephrology (ASN) Kidney Week 2025
ST. LOUIS, Oct. 30, 2025 (GLOBE NEWSWIRE) -- MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that data from the Company’s transdermal GFR technology has been accepted for an oral presentation at the upcoming American Society of Nephrology (ASN) Kidney Week 2025 in Houston, TX, November 5-9, 2025.
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding MediBeacon
Sign Up For FreeTo access detailed company insights
MediBeacon is a medical technology company that specializes in the development of fluorescent tracer agents and transdermal measurement systems. Their flagship product, the Transdermal GFR System (TGFR), allows for non-invasive monitoring of kidney function through a sensor placed on the skin. The company targets a range of clients including leadin... Read More
